共 50 条
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
被引:25
|作者:
Burgy, Olivier
[1
,2
]
Loriod, Sabrina
[1
,2
]
Beltramo, Guillaume
[1
,2
,3
,4
]
Bonniaud, Philippe
[1
,2
,3
,4
]
机构:
[1] Univ Bourgogne Franche Comte, Fac Med & Pharm, INSERM UMR LNC 1231, LabEX LipSTIC, F-21000 Dijon, France
[2] Univ Hosp Dijon Bourgogne, Reference Ctr Rare Lung Dis, F-21000 Dijon, France
[3] Univ Hosp Dijon Bourgogne, Dept Pulm Med, F-21000 Dijon, France
[4] Univ Hosp Dijon Bourgogne, Intens Care Unit, F-21000 Dijon, France
来源:
关键词:
extracellular lipids;
lipid metabolism;
idiopathic pulmonary fibrosis;
PROSTAGLANDIN E-2 RESISTANCE;
LYSOPHOSPHATIDIC ACID;
RECEPTOR ANTAGONIST;
SPHINGOLIPID METABOLISM;
MESENCHYMAL TRANSITION;
MOLECULAR-MECHANISMS;
THERAPEUTIC TARGETS;
CHOLINE TRANSPORTER;
CELL-PROLIFERATION;
KENNEDY PATHWAY;
D O I:
10.3390/cells11071209
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Lipids are major actors and regulators of physiological processes within the lung. Initial research has described their critical role in tissue homeostasis and in orchestrating cellular communication to allow respiration. Over the past decades, a growing body of research has also emphasized how lipids and their metabolism may be altered, contributing to the development and progression of chronic lung diseases such as pulmonary fibrosis. In this review, we first describe the current working model of the mechanisms of lung fibrogenesis before introducing lipids and their cellular metabolism. We then summarize the evidence of altered lipid homeostasis during pulmonary fibrosis, focusing on their extracellular forms. Finally, we highlight how lipid targeting may open avenues to develop therapeutic options for patients with lung fibrosis.
引用
收藏
页数:23
相关论文